Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenström macroglobulinemia does not indicate failure of response

Irene M. Ghobrial, Daniel Z. Uslan, Timothy G. Call, Thomas E. Witzig, Morie A. Gertz

Research output: Contribution to journalArticle

32 Scopus citations

Fingerprint Dive into the research topics of 'Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenström macroglobulinemia does not indicate failure of response'. Together they form a unique fingerprint.

Medicine & Life Sciences